The Current Ratio as of November 2025 (TTM) for Bafna Pharmaceuticals Limited (BAFNAPHARM.BO) is 1.88

According to Bafna Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Current Ratio is 1.88. This represents a change of 90.96% compared to the average of 0.98 of the last 4 quarters.

Bafna Pharmaceuticals Limited (BAFNAPHARM.BO) Historical Current Ratio (quarterly & annually)

How has BAFNAPHARM.BO Current Ratio performed in the past?

The mean historical Current Ratio of Bafna Pharmaceuticals Limited over the last ten years is 1.80. The current 1.88 Current Ratio has changed 10.32% with respect to the historical average. Over the past ten years (40 quarters), BAFNAPHARM.BO's Current Ratio was at its highest in in the September 2023 quarter at 2.06. The Current Ratio was at its lowest in in the December 2022 quarter at 0.

Bafna Pharmaceuticals Limited (BAFNAPHARM.BO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Bafna Pharmaceuticals Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bafna Pharmaceuticals Limited (BAFNAPHARM.BO) Average Current Ratio

How has BAFNAPHARM.BO Current Ratio performed in the past?

The current Current Ratio of Bafna Pharmaceuticals Limited (BAFNAPHARM.BO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Bafna Pharmaceuticals Limited (BAFNAPHARM.BO) Current Ratio vs. Peers

How is BAFNAPHARM.BO’s Current Ratio compared to its peers?

Bafna Pharmaceuticals Limited’s Current Ratio is less than Ortin Laboratories Limited (3.11), greater than Trimurthi Limited (0), greater than Parenteral Drugs (India) Ltd. (0.06), greater than Chandra Bhagat Pharma Limited (1.41), greater than Vivimed Labs Ltd. (0.80), less than Ganga Pharmaceuticals Limited (4.28), greater than Fabino Enterprises Ltd (1.46), greater than Ind-Swift Limited (1.42), greater than Ind-Swift Limited (1.42), greater than Opto Circuits (India) Ltd. (0.16),

Build a custom stock screener for Bafna Pharmaceuticals Limited (BAFNAPHARM.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bafna Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bafna Pharmaceuticals Limited (BAFNAPHARM.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bafna Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.